DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / American depositary shares, each representing one equity share
Symbol
RDY on NYSE
Shares outstanding
834,731,296
Price per share
$13.71
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
106,413,284
Total reported value
$1,494,001,797
% of total 13F portfolios
0%
Share change
-444,914
Value change
-$6,180,450
Number of holders
231
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Prasad G V 14% $1,607,395,312 113,356,510 K. Satish Reddy 17 Sep 2025

As of 31 Dec 2025, 231 institutional investors reported holding 106,413,284 shares of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY). This represents 13% of the company’s total 834,731,296 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) together control 11% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Robeco Institutional Asset Management B.V. 1.6% 13,154,524 +0.54% 0.26% $184,689,516
BlackRock, Inc. 1.2% 10,298,005 -7.7% 0% $144,583,985
ROYAL BANK OF CANADA 1.1% 9,549,276 -6% 0.02% $134,085,000
MORGAN STANLEY 1.1% 8,926,050 +41% 0.01% $125,321,764
RENAISSANCE TECHNOLOGIES LLC 0.99% 8,255,128 -6% 0.18% $115,901,997
Aikya Investment Management Ltd 0.88% 7,338,525 +9.3% 23% $103,032,891
JPMORGAN CHASE & CO 0.65% 5,467,449 -9.3% 0.01% $76,762,983
DIMENSIONAL FUND ADVISORS LP 0.64% 5,357,161 +0.08% 0.02% $75,215,781
VANGUARD GROUP INC 0.6% 5,027,272 -1.9% 0% $70,582,899
BNP PARIBAS FINANCIAL MARKETS 0.5% 4,152,566 0% 0.04% $58,302,027
STATE STREET CORP 0.48% 3,989,069 -4.1% 0% $56,006,529
ACADIAN ASSET MANAGEMENT LLC 0.26% 2,141,280 +6.8% 0.05% $30,054,000
BESSEMER GROUP INC 0.17% 1,420,066 +5.1% 0.03% $19,936,000
AMERICAN CENTURY COMPANIES INC 0.16% 1,351,361 +13% 0.01% $18,973,108
LAZARD ASSET MANAGEMENT LLC 0.14% 1,168,562 +52% 0.03% $16,406,610
Creative Planning 0.14% 1,162,252 -8% 0.01% $16,318,018
NORTHERN TRUST CORP 0.13% 1,090,136 -2.6% 0% $15,305,509
UBS Group AG 0.12% 986,478 -20% 0% $13,850,150
Caisse de depot et placement du Quebec 0.08% 677,700 +20% 0.02% $9,514,908
JANE STREET GROUP, LLC 0.07% 569,353 -52% 0.01% $7,993,716
MARSHALL WACE, LLP 0.06% 516,256 +1699% 0.01% $7,248,234
Fisher Asset Management, LLC 0.06% 506,043 -70% 0% $7,104,842
BANK OF AMERICA CORP /DE/ 0.06% 496,925 +22% 0% $6,976,827
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 0.05% 433,385 +0.57% 0% $6,084,725
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 0.05% 400,000 0% 0% $5,616,000

Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 106,413,284 $1,494,001,797 -$6,180,450 $14.04 231
2025 Q3 107,046,728 $1,496,505,057 -$18,824,134 $13.98 227
2025 Q2 107,490,178 $1,615,554,376 -$2,437,828 $15.03 239
2025 Q1 109,568,130 $1,445,145,982 -$147,804,573 $13.19 239
2024 Q4 118,585,675 $1,871,315,562 +$1,379,421,949 $15.79 246
2024 Q3 22,323,793 $1,773,509,164 -$32,845,620 $79.45 219
2024 Q2 24,129,104 $1,838,811,719 +$25,813,649 $76.19 221
2024 Q1 23,624,631 $1,732,414,047 +$4,316,081 $73.35 230
2023 Q4 23,549,346 $1,638,068,047 -$19,538,179 $69.58 223
2023 Q3 22,552,672 $1,508,022,257 +$123,782,702 $66.87 212
2023 Q2 20,723,050 $1,307,742,762 +$121,928,914 $63.11 191
2023 Q1 18,804,291 $1,070,382,001 +$136,751,438 $56.93 187
2022 Q4 16,423,176 $849,847,851 +$3,224,170 $51.75 160
2022 Q3 16,349,824 $856,712,431 +$35,896,390 $52.34 147
2022 Q2 15,653,996 $866,231,781 -$30,425,047 $55.39 148
2022 Q1 16,608,544 $923,504,810 +$4,920,142 $55.73 144
2021 Q4 16,496,810 $1,073,027,505 -$47,497,883 $65.41 141
2021 Q3 16,964,108 $1,105,536,697 -$93,370,525 $65.14 142
2021 Q2 18,379,985 $1,350,931,522 +$10,457,878 $73.51 156
2021 Q1 18,276,597 $1,128,117,710 -$17,322,858 $61.39 159
2020 Q4 19,125,629 $1,364,282,518 -$153,956,523 $71.29 170
2020 Q3 21,329,258 $1,481,500,793 -$17,904,382 $69.56 183
2020 Q2 21,616,772 $1,145,533,854 +$16,564,346 $53.01 167
2020 Q1 21,329,368 $861,309,678 -$4,218,038 $40.33 143
2019 Q4 21,438,572 $870,084,792 +$18,200,719 $40.58 143
2019 Q3 20,985,453 $795,412,395 -$26,186,555 $37.89 148
2019 Q2 21,654,714 $811,493,463 +$17,752,465 $37.47 146
2019 Q1 21,145,526 $856,437,692 +$30,798,825 $40.50 141
2018 Q4 20,415,214 $769,607,321 +$59,512,518 $37.70 142
2018 Q3 18,900,291 $650,214,052 -$43,956,397 $34.60 122
2018 Q2 20,321,786 $654,386,435 -$49,621,742 $32.20 130
2018 Q1 21,776,595 $711,493,019 +$108,057 $32.69 119
2017 Q4 21,751,667 $816,953,752 -$37,479,890 $37.56 116
2017 Q3 22,729,401 $811,012,307 -$95,718,487 $35.68 116
2017 Q2 25,280,563 $1,065,074,046 +$13,001,072 $42.14 127
2017 Q1 24,998,986 $1,003,880,481 -$48,350,770 $40.15 132
2016 Q4 27,315,628 $1,237,695,092 +$11,132,499 $45.28 161
2016 Q3 26,671,789 $1,238,813,813 -$11,598,960 $46.42 154
2016 Q2 26,837,854 $1,392,008,743 -$12,404,048 $51.23 155
2016 Q1 26,892,330 $1,220,577,828 -$88,233,808 $45.19 157
2015 Q4 28,820,386 $1,337,495,830 +$25,681,228 $46.29 169
2015 Q3 28,014,528 $1,789,938,205 +$197,320,692 $63.91 201
2015 Q2 24,973,479 $1,381,318,862 +$28,786,696 $55.32 186
2015 Q1 24,488,756 $1,395,870,125 -$54,865,208 $57.10 170
2014 Q4 25,475,072 $1,284,844,060 +$45,980,275 $50.45 164
2014 Q3 24,234,657 $1,273,510,655 -$18,359,585 $52.55 157
2014 Q2 25,553,686 $1,103,106,351 +$52,687,519 $43.15 167
2014 Q1 24,299,894 $1,065,961,113 +$91,925,526 $43.90 164